Abstract:OBJECTIVE:To investigate the metabolism of lipid, calcium and phosphorus in women with endometriosis. METHODS:Clinical data of 223 patients with endometriosis and 200 patients without endometriosis were retrospectively analyzed. Electrochemiluminoimmunoassay was used to detect the levels of serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone (T), estradiol (E2) and progesterone (P), and photoelectric colorimetry was used to determine the concentrations of serum triglyceride (TG), total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL), calcium and phosphorus in the patients with and without endometriosis. RESULTS:The levels of serum P were 2.0 nmol/L and 1.8 nmol/L in endometriosis patients with age < or = 35 years old (case group A) and > 35 years old (case group B), and 1.6 nmol/L and 1.2 nmol/L in patients without endometriosis at age < or = 35 years old (control group A) and > 35 years old (control group B), respectively. A significant difference was found between case group A and control group A, and between case group B and control group B. The levels of serum LH was significantly higher in case group B (7.2 U/L) than that in control group B (6.1 U/L), however, there was no significant difference between case group A (7.0 U/L) and control group A (6.5 U/L). Also no significant difference in serum FSH, T and E2 levels was found between case group A (respectively, 6.2 U/L, 1.1 nmol/L and 269 pmol/L) and control group A (respectively, 6.3 U/L, 1.1 nmol/L and 264 pmol/L), also between case group B (respectively, 6.6 U/L, 1.0 nmol/L and 345 pmol/L) and control group B (6.6 IU/L, 0.9 nmol/L and 279 pmol/L). The concentrations of serum TG in case group A and B (0.71 mmol/L and 0.72 mmol/L) were significantly lower than in control group A and B (0.92 mmol/L and 1.08 mmol/L), respectively. The concentrations of serum LDL in case group A and B [(2.2 +/- 0.5) mmol/L and (2.4 +/- 0.6) mmol/L]were also significantly lower than in control group A and B [(2.4 +/- 0.7) mmol/L and (2.62 +/- 0.63) mmol/L], respectively. However, the concentrations of serum HDL in case group A and B [(1.62 +/- 0.31) mmol/L and (1.53 +/- 0.32) mmol/L] were significantly higher than in control group A and B [(1.48 +/- 0.21) mmol/L and (1.37 +/- 0.22) mmol/L] , respectively. In addition, the concentrations of serum TC were not significantly different between case group A and control group A [(4.2 +/- 0.7) mmol/L and (4.29 +/- 0.71) mmol/L], and between case group B and control group B [(4.4 +/- 0.8) mmol/L and (4.5 +/- 0.7) mmol/L]. The levels of serum phosphorus in case group A and B [(1.01 +/- 0.22) mmol/L and (0.89 +/- 0.18 mmol/L] were significantly lower than in control group A and B [1.23 +/- 0.24 mmol/L and (1.10 +/- 0.13) mmol/L], respectively. But the levels of serum calcium had no significant difference between case group A and control group A [(2.33 +/- 0.23) mmol/L and (2.41 +/- 0.12) mmol/L], and between case group B and control group B [(2.40 +/- 0.28) mmol/L and (2.42 +/- 0.20) mmol/L]. CONCLUSION:The abnormal metabolism of lipid and phosphorus, and the higher levels of serum P may playing a role in the pathogenesis of endometriosis.

Gut Microbiome–Estrobolome Profile in Reproductive-Age Women with Endometriosis

[Associations of Metabolism of Lipid, Calcium and Phosphate in Endometriosis].

A comprehensive cell profiling reveals new cell subtypes and immune dysfunction in peritoneal fluid of endometriosis

Single-cell Transcriptomic Analysis of Endometriosis Provides Insights into Fibroblast Fates and Immune Cell Heterogeneity

Microbiota composition and distribution along the female reproductive tract of women with endometriosis.

Gut microbiota imbalance and its correlations with hormone and inflammatory factors in patients with stage 3/4 endometriosis

Gut microbiome in endometriosis: a cohort study on 1000 individuals

The colonized microbiota composition in the peritoneal fluid in women with endometriosis

Endometrial Dysbiosis: A Possible Association with Estrobolome Alteration

The potential role of gut microbiota in the occurrence and development of endometriosis

Intricate Connections between the Microbiota and Endometriosis

Endometriosis is a disease of immune dysfunction, which could be linked to microbiota

Unraveling the microbial puzzle: exploring the intricate role of gut microbiota in endometriosis pathogenesis

Endometrial Microbiota in Women with and Without Adenomyosis: A Pilot Study

Estrobolome dysregulation is associated with altered immunometabolism in a mouse model of endometriosis

Endometrial microbiota alteration in female patients with endometrial polyps based on 16S rRNA gene sequencing analysis

Gut and Vaginal Microbiota in the Endometriosis: Systematic Review and Meta-Analysis

Effects of the gut microbiota and its metabolite short-chain fatty acids on endometriosis

Role of the gut microbiota in the pathogenesis of endometriosis: a review

Endometrial microbial dysbiosis and metabolic alteration promote the development of endometrial cancer

The Endometrial Microbiota: Challenges and Prospects